Oral Lactoferrin Treatment of Experimental Oral Candidiasis in Mice
AUTOR(ES)
Takakura, Natsuko
FONTE
American Society for Microbiology
RESUMO
We assessed the potential of lactoferrin (LF), a multifunctional milk protein, for treatment of oral candidiasis with immunosuppressed mice, which have local symptoms characteristic of oral thrush. Oral administration of bovine LF in drinking water starting 1 day before the infection significantly reduced the number of Candida albicans in the oral cavity and the score of lesions on the tongue on day 7 after the inoculation. The symptomatic effect of LF was confirmed by macroscopic and microscopic observations of the tongue's surface. Similar effects were also observed upon administration of LF pepsin hydrolysate, but not lactoferricin B, an antimicrobial peptide of LF. The anticandidal activity of LF was evident on administration either in drinking water or by intragastric intubation with a stomach tube. These results suggest that the effect of LF in this oral candidiasis model is not due to direct antifungal action. In conclusion, LF could have potential as a food component supporting antifungal drug treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=166093Documentos Relacionados
- 5-Fluorocytosine in the Treatment of Experimental Candidiasis in Immunosuppressed Mice
- Experimental Oral Candidiasis in Animal Models
- EXPERIMENTAL CANDIDIASIS IN CORTISONE-TREATED MICE
- Bleomycin therapy of experimental disseminated candidiasis in mice.
- Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment
